Current API pipeline
R&D Advanced stage
| Aniracetam | Doxercalciferol | Rasagiline |
| Carvedilol hydrochloride | Irbesartan | Saxagliptin |
| Clopidogrel besylate | Prasugrel | Tapentadol hydrochloride |
| Dabigatran etexilate | Pregabalin |
R&D Early development / evaluation stage
| Aliskiren hemifumarate | Dapagliflozin | Retigabine / Ezogabine |
| Apixaban | Fingolimod | Rilpivirine |
| Avanafil | Glatiramer acetate | Rivaroxaban |
| Azilsartan medoxomil | Indacaterol | Roflumilast |
| Bazedoxifene acetate | Linaclotide | Ticagrelor |
| Belatacept | Linagliptin | Tofacitinib citrate |
| Boceprevir | Lurasidone | Vernakalant hydrochloride |
| Dalcetrapib | Maraviroc | Vilazodone hydrochloride |
Latest news
CEP for Baclofen available
Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...
Polpharma – the most innovative company in Poland
Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...